Omidenepag: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Omidenepag. Educational only — not medical advice.
Labeled uses
Omlonti (omidenepag isopropyl ophthalmic solution) 0.002%, is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
Source: FDA labeling via NIH DailyMed (set 8e440b2c…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.